Polymeric Nanoparticles for Pharmaceutical Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (31 December 2024) | Viewed by 1641
Special Issue Editor
Special Issue Information
Dear Colleagues,
In recent years, interest in using polymeric nanoparticles for drug delivery in pharmaceuticals has surged. These nanoparticles offer a versatile approach, comprising biocompatible and biodegradable polymers designed to encapsulate drugs. Upon administration, they enable controlled release and targeted delivery, overcoming barriers like poor solubility and enzymatic degradation. Their surface properties can be tailored for specific interactions with biological targets, minimizing off-target effects. Additionally, polymeric nanoparticles sustain drug release, improving patient compliance. By adjusting their characteristics, researchers enhance drug delivery efficiency.
This Special Issue will include research and reviews on polymeric nanoparticles' pharmaceutical applications and we invite researchers and drug developers to contribute original articles, thereby advancing drug delivery systems and therapeutics.
Dr. Luiza Abrahão Frank
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- polymeric nanoparticle
- drug delivery
- controlled release
- therapeutic efficacy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
